PTSD Medications After Personal Injury: What Attorneys and Patients Need to Know

James Wong — Founder & Pharmacist, LienScripts | February 15, 2026 | 8 min read

Motor vehicle accidents and assaults are leading causes of civilian PTSD. Learn how FDA-approved pharmacotherapy works, why insurers routinely deny these medications, and how a pharmacy lien ensures uninterrupted access to the full PTSD regimen.

PTSD After Personal Injury: A Recognized and Compensable Condition

Post-traumatic stress disorder is not limited to combat veterans. According to the DSM-5, PTSD can be triggered by any event that involves actual or threatened death, serious injury, or sexual violence — a definition that squarely encompasses motor vehicle accidents, pedestrian knockdowns, assaults, and workplace injuries.

Research consistently identifies MVAs as the single leading cause of civilian PTSD in the United States, with prevalence estimates ranging from 20 to 45 percent of serious-crash survivors. Assault survivors have similarly high rates. Yet despite this well-documented link, PTSD medication claims in personal injury cases are routinely disputed, delayed, and denied by liability insurers — leaving injured claimants to choose between going without treatment or paying out of pocket while their case is pending.

A pharmacy lien eliminates that forced choice. This article explains how PTSD pharmacotherapy works, what first-line and second-line options look like, why insurers push back, and how your attorney can use the pharmacy record to strengthen the psychological damages portion of the demand.

DSM-5 Diagnostic Criteria for PTSD

The DSM-5 requires that all of the following criteria be met for a PTSD diagnosis:

Criterion A (Trauma exposure): Direct experience, witnessing, or learning about a traumatic event involving actual or threatened death, serious injury, or sexual violence
Criterion B (Intrusion symptoms): Recurrent involuntary memories, nightmares, dissociative flashbacks, or intense psychological or physiological reactions to trauma cues
Criterion C (Avoidance): Persistent avoidance of trauma-related thoughts, feelings, people, places, or situations
Criterion D (Negative alterations in cognition and mood): Distorted blame, persistent negative emotions, diminished interest in activities, feelings of detachment
Criterion E (Alterations in arousal and reactivity): Hypervigilance, exaggerated startle response, sleep disturbance, irritability, difficulty concentrating
Duration: Symptoms present for more than one month
Functional impairment: Clinically significant distress or impairment in social, occupational, or other important areas of functioning

The formal diagnosis typically comes from a psychiatrist or licensed psychologist and is documented in treatment records. That diagnosis record is essential for the demand package.

[!KEY] A PTSD diagnosis supported by psychiatric records and a documented medication regimen creates a paper trail that quantifies psychological damages in ways that subjective testimony alone cannot.

First-Line Pharmacotherapy: FDA-Approved Options

The VA/DoD Clinical Practice Guideline for PTSD (2023 update) and the American Psychological Association both recommend selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) as first-line pharmacological treatment.

Sertraline (Zoloft) — FDA-approved specifically for PTSD. Sertraline reduces intrusive symptoms, hyperarousal, and avoidance behavior. It is typically titrated from 25 mg to a therapeutic range of 100–200 mg/day. Full symptom response often requires 8–12 weeks, meaning claimants must remain on medication throughout much of their case.

Paroxetine (Paxil) — The second FDA-approved medication for PTSD. Paroxetine has additional anxiolytic properties that benefit claimants with comorbid panic disorder, which is common after traumatic injury. Dosing typically ranges from 20–60 mg/day.

Venlafaxine (Effexor XR) — While not FDA-approved specifically for PTSD, venlafaxine (an SNRI) is strongly recommended by VA/DoD CPG and is widely prescribed by psychiatrists treating post-traumatic symptoms. Its dual serotonin-norepinephrine action addresses both mood and somatic pain symptoms.

[!SOURCE] VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder, Version 4.0 (2023). Available at: https://www.healthquality.va.gov/guidelines/MH/ptsd/

Second-Line Medications Commonly Used in PI Cases

Many PTSD patients require augmentation strategies when first-line agents provide incomplete relief. In personal injury cases, these second-line medications appear frequently in pharmacy records and require documentation of the clinical rationale.

Prazosin — An alpha-1 adrenergic blocker originally developed for hypertension. Prazosin has strong evidence for reducing trauma-related nightmares and sleep disturbance in PTSD. Typical dosing is 1–15 mg at bedtime. It is off-label for PTSD but widely used and guideline-supported.

Mirtazapine (Remeron) — A noradrenergic and specific serotonergic antidepressant (NaSSA) with powerful sedating properties at low doses. Mirtazapine addresses sleep disruption, appetite loss, and depressed mood simultaneously — a useful combination when PTSD co-occurs with depression (which it does in a majority of cases).

Hydroxyzine (Vistaril, Atarax) — A first-generation antihistamine with anxiolytic properties. Hydroxyzine is prescribed for acute anxiety flare-ups and provides rapid relief without the dependency concerns associated with benzodiazepines. It is commonly used as a bridging medication while SSRIs reach therapeutic levels.

Why Insurers Deny PTSD Medications

Liability insurers dispute PTSD pharmacotherapy on several grounds:

Causation challenges: Insurers argue the claimant had pre-existing anxiety or depression unrelated to the accident. The psychiatric evaluation and medication initiation date relative to the injury are critical here.
Prior authorization barriers: Brand-name medications (Paxil CR, Effexor XR) often require prior authorization and documentation of failure with generic alternatives — a process that can take weeks.
Specialty medication gatekeeping: Prazosin and mirtazapine are frequently flagged for review because they are not primarily marketed as psychiatric medications, requiring the prescribing physician to document the PTSD-specific clinical rationale.
Medpay and health insurance exhaustion: Even when the claimant has coverage, Medpay limits are quickly exhausted on physical injuries, leaving psychiatric medications unfunded.

[!KEY] A pharmacy lien means the claimant receives every prescribed PTSD medication on day one, without insurance approval battles, without out-of-pocket expense, and without treatment gaps that defense counsel can use to argue the condition resolved.

How Pharmacy Lien Coverage Works for PTSD Regimens

Under a pharmacy lien arrangement, LienScripts dispenses all prescribed PTSD medications — SSRIs, SNRIs, prazosin, mirtazapine, hydroxyzine, and any adjunctive medications — with repayment deferred to case settlement. There are no prior authorization hurdles, no formulary restrictions, and no coverage denials.

For the prescribing psychiatrist, the process is straightforward: write the prescriptions, send them to LienScripts, and the patient picks up or receives their medications without any financial barrier.

For the attorney, every medication dispensed is documented in the pharmacy record with the drug name, strength, dispense date, prescribing physician, and diagnosis code. That record becomes part of the demand package.

Documenting PTSD Pharmacotherapy in the Demand Package

The pharmacy record is not just a billing document. When structured correctly, it serves as powerful evidence of psychological damages:

Treatment continuity: A continuous pharmacy record showing monthly refills of sertraline or paroxetine over 12–24 months demonstrates that PTSD was not a transient reaction but a persistent, treated psychiatric condition.

Medication escalation: When the pharmacy record shows dose increases or medication additions (adding prazosin for nightmares after the SSRI alone proved insufficient), it corroborates the treating psychiatrist's notes about symptom severity.

Diagnosis codes: Every dispense is filled under the psychiatrist's diagnosis — ICD-10 code F43.10 (PTSD, unspecified) or F43.11/F43.12 (acute/chronic) appears on each prescription record, providing a consistent, documented diagnostic trail.

Economic damages quantification: The total medication cost billed under the lien becomes a line item in the economic damages calculation, distinct from general damages for pain and suffering.

Comorbidity documentation: When the pharmacy record shows both PTSD medications and pain medications being filled simultaneously, it reinforces the interconnected nature of the psychological and physical injuries — a combination that typically increases overall case value.

Special Considerations for Assault and Sexual Violence Cases

Motor vehicle accidents are not the only PI contexts where PTSD appears. Assault, sexual violence, and premises liability cases (robbery, attack in a parking structure) frequently produce PTSD diagnoses with high medication complexity.

In these cases, the pharmacy record takes on additional significance because it provides objective, third-party documentation of an ongoing psychiatric condition — particularly important in cases where the claimant's credibility is at issue or where the defense will aggressively challenge the severity of psychological harm.

[!SOURCE] Kessler RC, et al. "Posttraumatic stress disorder in the National Comorbidity Survey." Archives of General Psychiatry. 1995;52(12):1048-1060. PMID: 7492257. (Foundational civilian PTSD prevalence data.)

Working with the Treating Psychiatrist

Attorneys handling PI cases with PTSD components should ensure the treating psychiatrist understands their role in documenting causation and functional impairment. Key documentation requests include:

A letter of medical necessity connecting the PTSD diagnosis to the accident
Progress notes that track symptom severity using validated scales (PCL-5)
Specific documentation of occupational impairment (inability to drive, missed work, avoidance of accident-related tasks)
A treatment plan that reflects the expected duration and cost of ongoing pharmacotherapy

When this documentation is paired with the pharmacy lien record, the result is a cohesive medical-legal narrative that is difficult for defense counsel to minimize.

Related Resources

Frequently Asked Questions

Which medications are FDA-approved specifically for PTSD?

Only two medications carry FDA approval specifically for PTSD: sertraline (Zoloft) and paroxetine (Paxil). However, VA/DoD Clinical Practice Guidelines also strongly recommend venlafaxine (Effexor XR) as a first-line option, and many psychiatrists use it routinely for post-traumatic symptoms.

Can a car accident cause PTSD severe enough to require long-term medication?

Yes. Motor vehicle accidents are the leading cause of civilian PTSD in the United States. Research shows that 20–45% of serious crash survivors develop PTSD, and many require pharmacotherapy for a year or more. The severity and duration depend on the nature of the crash, the claimant's vulnerability factors, and whether timely treatment was initiated.

Why do insurers deny PTSD medications in personal injury cases?

Insurers challenge PTSD medications on causation grounds (arguing the condition predates the accident), through prior authorization requirements for brand-name drugs, and by questioning whether the prescribing physician is a qualified psychiatrist. A pharmacy lien sidesteps all of these barriers, dispensing medications immediately while the causation dispute is resolved at settlement.

How does a pharmacy lien help document PTSD in the demand package?

The pharmacy record created under a lien shows every PTSD medication dispensed, the diagnosis code, the prescribing psychiatrist, and the dispense dates. A continuous refill record over many months demonstrates a persistent, treated psychiatric condition. Medication escalations — adding prazosin for nightmares or increasing the SSRI dose — corroborate the treating physician's clinical narrative about symptom severity.

Is prazosin covered under a pharmacy lien for PTSD nightmares?

Yes. LienScripts covers the full prescribed PTSD regimen, including adjunctive medications like prazosin for nightmares, mirtazapine for sleep and appetite, and hydroxyzine for acute anxiety — all without prior authorization or out-of-pocket expense to the patient.